PNC Financial Services Group Inc. Acquires 13,797 Shares of DENTSPLY SIRONA Inc. $XRAY

PNC Financial Services Group Inc. increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 88.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,342 shares of the medical instruments supplier’s stock after purchasing an additional 13,797 shares during the quarter. PNC Financial Services Group Inc.’s holdings in DENTSPLY SIRONA were worth $466,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vise Technologies Inc. bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $589,000. Allworth Financial LP boosted its holdings in DENTSPLY SIRONA by 56.9% in the second quarter. Allworth Financial LP now owns 6,196 shares of the medical instruments supplier’s stock valued at $98,000 after acquiring an additional 2,247 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $2,877,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $978,000. Finally, Parkside Financial Bank & Trust raised its holdings in DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $10.73 on Tuesday. The business has a 50-day simple moving average of $12.23 and a 200 day simple moving average of $14.23. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $20.59. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of -2.26, a PEG ratio of 0.81 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The firm had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company’s revenue was down 4.9% on a year-over-year basis. During the same period last year, the business posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

XRAY has been the subject of several recent analyst reports. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research report on Friday, November 7th. UBS Group decreased their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a report on Tuesday, October 28th. JPMorgan Chase & Co. dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Zacks Research lowered DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $16.08.

Read Our Latest Research Report on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.